Salter Malcolm

C4 Therapeutics, Inc. · Director

Salter Malcolm is listed in filings as Director at C4 Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 21, 2024, including 1 public disclosure. Recent filings connect the profile to C4 Therapeutics, Inc. (CCCC). The current snapshot covers public activity from Jun 21, 2024. Reported amounts are shown as $131.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.